[Adherence of Type 2 Diabetes Mellitus approach: Current situation and possible solutions]

Domingo Orozco-Beltrán, Manel Mata-Cases, Sara Artola, Pedro Conthe, Javier Mediavilla, Carlos Miranda, Domingo Orozco-Beltrán, Manel Mata-Cases, Sara Artola, Pedro Conthe, Javier Mediavilla, Carlos Miranda

Abstract

Objectives: Define the impact and causes of non-adherent type-2 diabetes mellitus (DM2) patients, possible solutions and the role of the different health care professionals involved in the treatment.

Design: Structured questionnaire rating by a two-round Delphi method.

Location: The study was conducted in the Primary Care settings.

Participants: The expert panel consisted of renowned medical professionals with extensive experience in diabetes.

Main measurements: Assessment through a 9-point Likert scale, of the degree of agreement or disagreement on 131 items grouped into 4 blocks: impact; causes of nonadherence; diagnosis of non-adherence, and possible causes, solutions and role of the different professionals involved in adherence.

Results: The participation rate was 76.31%. The primary care health professionals agreed on 110 of the 131 proposals statements (84%), showing agreement on 102 items (77.9%) and disagreement in 8 (6.1%). Consensus was not reached on 21 items.

Conclusions: The lack of adherence of DM2 patients makes the achievement of therapeutic control difficult. The medical practice needs to have specific training and enough resources to reduce the impact of the lack of therapeutic compliance.

Keywords: Adherencia terapéutica; Atención primaria; Delphi technique; Diabetes mellitus tipo 2; Diabetes mellitus type 2; Family practice; Medicina de familia; Patient compliance; Primary health care; Técnica Delphi.

Copyright © 2015 Elsevier España, S.L.U. All rights reserved.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6877892/bin/fx1.jpg
Esquema general del estudio:

References

    1. World Health Organization. Diabetes Fact sheet No. 312. Updated March 2013 [consultado 18 Nov 2014]. Disponible en:
    1. Soriguer F., Goday A., Bosch-Comas A., Bordiu E., Calle-Pascual A., Carmena R. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study. Diabetologia. 2012;55:88–93.
    1. Ruiz-Ramos M., Escolar-Pujolar A., Mayoral-Sánchez E., Corral-San Laureano F., Fernández-Fernández I. La diabetes mellitus en España: mortalidad, prevalencia, incidencia, costes económicos y desigualdades. Gac Sanit. 2006;20(Suppl 1):15–24.
    1. Vicente-Herrero M.T., Terradillos García M.J., Capdevila García L.M., Ramírez Iñíguez de la Torre M.V., López-González A.A. Costes por incapacidad temporal en España derivados de la diabetes mellitus y sus complicaciones. Endocrinol Nutr. 2013;60:447–455.
    1. Conthe P., Márquez Contreras E., Aliaga Pérez A., Barragán García B., Fernández de Cano Martín M.N., González Jurado M. Treatment compliance in chronic illness: Current situation and future perspectives. Rev Clin Esp. 2014;214:336–344.
    1. López-Simarro F., Brotons C., Moral I., Cols-Sagarra C., Selva A., Aguado-Jodar A. Inercia y cumplimiento terapéutico en pacientes con diabetes mellitus tipo 2 en atención primaria. Med Clin (Barc) 2012;138:377–384.
    1. González-Clemente J.M., Font B., Lahoz R., Llauradó G., Gambús G., Grupo de investigadores del Estudio INERCIA Inercia clínica en pacientes con diabetes mellitus tipo 2 no insulinizados en tratamiento con hipoglucemiantes orales. Estudio INERCIA. Med Clin (Barc). 2014;142:478–484.
    1. Márquez Contreras E., Martell Claros N., Gil Guillen V., Casado Martínez J.J., Martin de Pablos J.L., Ferraro García J. El cumplimiento terapéutico con insulina en el tratamiento de la diabetes mellitus tipo 2: estudio CUMINDIAB. Aten Primaria. 2012;44:74–81.
    1. Carratalá-Munuera M.C., Gil-Guillen V.F., Orozco-Beltrán D., Navarro-Pérez J., Caballero-Martínez F., Álvarez-Guisasola F. Barriers associated with poor control in Spanish diabetic patients. A consensus study. Int J Clin Pract. 2013;67:888–894.
    1. The RAND/UCLA Appropriateness Method User's Manual | RAND. [consultado 8 Nov 2014]. Disponible en:
    1. Vinagre I., Mata-Cases M., Hermosilla E., Morros R., Fina F., Rosell M. Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain) Diabetes Care. 2012;35:774–779.
    1. García-Pérez L.E., Álvarez M., Dilla T., Gil-Guillén V., Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013;4:175–194.
    1. Thinking outside the pillbox. A system-wide approach to improving patient medication adherence for chronic disease. New England Healthcare Institute; 2009 [consultado 18 Nov 2014]. Disponible en:
    1. Adherencia al tratamiento farmacológico en patologías crónicas. NFAC Información Farmacoterapéutica de la Comarca. 2011;19:5.
    1. Paz S., González Segura D., Raya Torres A., Lizán L. Principales factores asociados al coste de la diabetes mellitus tipo 2: revisión de la literatura. Av Diabetol. 2014;30:34–44.
    1. Torres I.V., Donlo I.C. Situación actual del control de la diabetes mellitus tipo 2 en España. Identificación de las principales barreras en la práctica clínica diaria. Med Clin (Barc). 2013;141(Suppl 2):3–6.
    1. Grant R., Adams A.S., Trinacty C.M., Zhang F., Kleinman K., Soumerai S.B. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007;30:807–812.
    1. Schmittdiel J.A., Uratsu C.S., Karter A.J., Heisler M., Subramanian U., Mangione C.M. Why don’t diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23:588–594.
    1. Ministerio de Sanidad, Servicios Sociales e Igualdad; Madrid: 2012. Estrategia en Diabetes del Sistema Nacional de Salud. Actualización.
    1. Cartera de Servicios de Atención Primaria. Ministerio de Sanidad y Política Social 2010 [consultado 18 Nov 2014]. Disponible en:
    1. Isla P., Castella E., Insa R., López C., Icart T., Blanco M. Proporción de carga asistencial generada por la Diabetes Mellitus en las consultas de enfermería de Atención Primaria de Salud. Endocrinol Nutr. 2007;54:54. 7.
    1. Conthe P, Márquez-Contreras E. Documento de consenso. Una aproximación multidisciplinar al problema de la adherencia terapéutica en las enfermedades crónicas: estado de la situación y perspectivas de futuro. MSD; 2012 [consultado 18 Nov 2015]. Disponible en:
    1. Márquez Contreras E. Evaluación práctica del incumplimiento. Hipertensión. 2008;25:8.
    1. De la Figuera M. Métodos de medida del cumplimiento terapéutico en la diabetes tipo 2. Hipertens Riesgo Vasc. 2012;29(Supl 1):5.
    1. Rodríguez Chamorro M.A., García-Jiménez E., Amariles P., Rodríguez Chamorro A., Faus M.J. Revisión de tests de medición del cumplimiento terapéutico utilizados en la práctica clínica. Aten Primaria. 2008;40:413–418.
    1. World Health Organization. Adherence to long-term therapies: Evidence for action. Ginebra: WHO; 2003 [consultado 18 Nov 2014]. Disponible en:
    1. Horton E., Cefalu W.T., Haines S.T., Siminerio L.M. Multidisciplinary interventions: Mapping new horizons in diabetes care. Diabetes Educ. 2008;34(Suppl 4):78S–89S.
    1. Wens J., Vermeire E., Royen P.V., Sabbe B., Denekens J. GPs’ perspectives of type 2 diabetes patients’ adherence to treatment: A qualitative analysis of barriers and solutions. BMC Fam Pract. 2005;6:20.
    1. Bohanny W., Wu S.F., Liu C.Y., Yeh S.H., Tsay S.L., Wang T.J. Health literacy, self-efficacy, and self-care behaviors in patients with type 2 diabetes mellitus. J Am Assoc Nurse Pract. 2013;25:495–502.
    1. González J.S., Peyrot M., McCarl L.A., Collins E.M., Serpa L., Mimiaga M.J. Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care. 2008;31:2398–2403.
    1. Fain J.A., Nettles A., Funnell M.M., Charron D. Diabetes patient education research: An integrative literature review. Diabetes Educ. 1999;25(6 Suppl):7–15.
    1. Al Hayek A.A., Robert A.A., al Dawish M.A., Zamzami M.M., Sam A.E., Alzaid A.A. Impact of an education program on patient anxiety, depression, glycemic control, and adherence to self-care and medication in type 2 diabetes. J Family Community Med. 2013;20:77–82.
    1. Debussche X. Is adherence a relevant issue in the self-management education of diabetes? A mixed narrative review. Diabetes Metab Syndr Obes. 2014;7:357–367.
    1. Alcantarilla Roura D., Güell Figa E., Bello Mayoraz J. La comunicación con el paciente y la adherencia al tratamiento. FMC. 2014;21:2.
    1. Brown S.A. Interventions to promote diabetes self-management: State of the science. Diabetes Educ. 1999;25(6 Suppl):52–61.
    1. Vermeire E., Wens J., van Royen P., Biot Y., Hearnshaw H., Lindenmeyer A. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;2:CD003638.
    1. Van Dam H.A., van der Horst F.G., Knoops L., Ryckman R.M., Crebolder H.F., van den Borne B.H. Social support in diabetes: A systematic review of controlled intervention studies. Patient Educ Couns. 2005;59:1–12.
    1. Haynes R.B., Ackloo E., Sahota N., McDonald H.P., Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
    1. Kripalani S., Yao X., Haynes R.B. Interventions to enhance medication adherence in chronic medical conditions: A systematic review. Arch Intern Med. 2007;167:540–550.
    1. Servicio Madrileño de Salud Adherencia terapéutica: estrategias prácticas de mejora. Notas Farmacoterapéuticas. 2006;13:7.
    1. Magkos F., Yannakoulia M., Chan J.L., Mantzoros C.S. Management of the metabolic syndrome and type 2 diabetes through lifestyle modification. Ann Rev Nutr. 2009;29:223–256.
    1. Newman S., Steed E., Mulligan K. McGraw-Hill International; Glasgow: 2009. Chronic Physical Illness: Self-Management And Behavioural Interventions.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel